Stock ARCH ARCH BIOPARTNERS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Arch Biopartners Inc. Toronto S.E.

Equities

ARCH

CA03938C1041

Market Closed - Toronto S.E.
Other stock markets
 20:56:49 25/06/2024 BST 		5-day change 1st Jan Change
1.65 CAD +1.85% Intraday chart for Arch Biopartners Inc. -1.79% +11.49%
06-18 Arch Biopartners Obtains University of Calgary Ethics Approval to Proceed with Phase II Trial MT
06-18 Arch Biopartners Announces University of Calgary Ethics Approval to Proceed with Phase II Trial for LSALT Peptide Targeting Cardiac Surgery Associated-Acute Kidney Injury (CS-AKI) CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Biotechnology & Medical Research

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
MODERNA, INC. Stock Moderna, Inc.
 52.73B -
LONZA GROUP AG Stock Lonza Group AG
 39B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
 38.52B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
 30.38B -
CELLTRION, INC. Stock Celltrion, Inc.
 26.39B
  1. Stock Market
  2. Equities
  3. ACHFF Stock
  4. ARCH Stock
  5. Charts Arch Biopartners Inc.
  6. Sector Chart